Janus Henderson Investors US’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | $119M | Buy |
982,224
+62,811
| +7% | +$7.61M | 0.1% | 258 |
|
|
2016
Q4 | $113M | Buy |
919,413
+65,266
| +8% | +$7.99M | 0.09% | 268 |
|
|
2016
Q3 | $105M | Sell |
854,147
-172,238
| -17% | -$21.1M | 0.09% | 291 |
|
|
2016
Q2 | $120M | Buy |
1,026,385
+84,590
| +9% | +$9.88M | 0.1% | 262 |
|
|
2016
Q1 | $131M | Buy |
941,795
+189,634
| +25% | +$26.4M | 0.11% | 237 |
|
|
2015
Q4 | $143M | Sell |
752,161
-36,052
| -5% | -$6.88M | 0.12% | 217 |
|
|
2015
Q3 | $123M | Sell |
788,213
-43,682
| -5% | -$6.83M | 0.11% | 229 |
|
|
2015
Q2 | $150M | Buy |
831,895
+158,847
| +24% | +$28.7M | 0.12% | 229 |
|
|
2015
Q1 | $117M | Buy |
673,048
+306,582
| +84% | +$53.1M | 0.1% | 273 |
|
|
2014
Q4 | $67.8M | Sell |
366,466
-116,524
| -24% | -$21.6M | 0.06% | 386 |
|
|
2014
Q3 | $80.1M | Buy |
482,990
+74,887
| +18% | +$12.4M | 0.07% | 322 |
|
|
2014
Q2 | $63.8M | Sell |
408,103
-11,440
| -3% | -$1.79M | 0.06% | 359 |
|
|
2014
Q1 | $63.8M | Sell |
419,543
-977,478
| -70% | -$149M | 0.06% | 360 |
|
|
2013
Q4 | $186M | Sell |
1,397,021
-16,637
| -1% | -$2.21M | 0.18% | 158 |
|
|
2013
Q3 | $164M | Sell |
1,413,658
-457,736
| -24% | -$53.2M | 0.16% | 164 |
|
|
2013
Q2 | $173M | Buy |
+1,871,394
| New | +$173M | 0.18% | 149 |
|